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Available online 5 July 2016Background: Radial Diffusivity (RD) has been suggested as a promising biomarker associated with the level of
myelination in MS lesions. However, the level of RD within the lesion is affected not only by loss of myelin
sheaths, but also by the degree of tissue destruction. Thismay lead to exaggeration of diffusivitymeasures, poten-
tially masking the effect of remyelination.
Objective: To test the hypothesis that the T2 hyperintense lesion edge that extends beyond the T1 hypointense
lesion core is less affected by tissue loss, and therefore amore appropriate target for imaging biomarker develop-
ment targeting de- and re-myelination.
Method: Pre- and post-gadolinium (Gd) enhanced T1, T2 and DTI images were acquired from 75 consecutive
RRMS patients. The optic radiation (OR) was identiﬁed in individual patients using a template-based method.
T2 lesions were segmented into T1-hypointense and T1-isointense areas and lesion masks intersected with the
OR. Average Radial, Axial and Mean diffusivity (RD, AD and MD) and fractional anisotropy (FA) were calculated
for lesions of the entire brain and the OR. In addition, Gd enhancing lesions were excluded from the analysis.
Results: 86% of chronic T2 lesions demonstrated hypointense areas on T1-weighted images, which typically occu-
pied the central part of each T2 lesion, taking about 40% of lesional volume. The T1-isointense component of the
T2 lesionwasmost commonly seen as a peripheral ring of relatively constant thickness (“T2-rim”).While chang-
es of diffusivity between adjacent normal appearing white matter and the “T2-rim” demonstrated a
disproportionally high elevation of RD compare to AD, the increase of water diffusion was largely isointense be-
tween the “T2-rim” and T1-hypointense parts of the lesion.
Conclusion: Distinct patterns of diffusivity within the central and peripheral components of MS lesions suggest
that axonal loss dominates in the T1 hypointense core. The effects of de/remyelination may be more readily de-
tected in the “T2-rim”, where there is relative preservation of structural integrity. Identifying and separating
those patterns has an important implication for clinical trials of both neuroprotective and, in particular,
remyelinating agents.
© 2016 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Recent interest in the development of remyelinating therapies has
increased demand for reliable in vivo surrogate markers of
remyelination. Quantiﬁcation of thediffusion characteristics of brain tis-
sue, in particular Radial Diffusivity, has been suggested as a promising
imaging biomarker associated with the level of tissue myelination.Society (NMSS), Novartis Save
is National Health and Medical
sity of Sydney, 8 Macquarie St.
istorner).
en access article under the CC BY-NCExperimental models of demyelination have demonstrated a close cor-
relation between degree ofmyelin loss and alterations in RD (Song et al.,
2005; Janve et al., 2013). In post-mortem studies of human MS brains,
elevation of RD was topographically linked to areas of histologically
identiﬁed demyelination (Schmierer et al., 2007; Schmierer et al.,
2008; Wang et al., 2015). A close relationship between increase in RD
and electrophysiological measures of demyelination was also reported
in patients with MS (Alshowaeir et al., 2014). However, some recent
studies have failed to demonstrate an unequivocal relationship between
increased RD and the degree of demyelination, suggesting that this
measure is not pathologically speciﬁc (Klawiter et al., 2012).
Currently, conventional MRI is the gold standard to identify focal in-
ﬂammatory demyelination in MS. Typically, acute T2 lesions comprise
an area of demyelination and surrounding edema. Resolution of acute-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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sion size, with a permanent residual lesion that includes demyelinated
(and partially remyelinated) axons (Schmierer et al., 2009) and areas
of expanded extracellular space. The widening of extracellular space is
believed to be caused by tissue destruction and may occupy up to 87%
of the lesion volume (Barnes et al., 1991; Miller, 2008). The majority
of chronic T2 lesions are also seen as hypointense areas on T1-weighted
images, although typically the change of the signal intensity on the T1-
weighted image occurs only in part of the T2 lesion (Barkhof and van
Walderveen, 1999). The level of T1 hypointensity varies signiﬁcantly
from slightly hypointense in comparison to surrounding NAWM to ap-
proaching the intensity of CSF, reﬂecting a variable degree of widening
of the extracellular space (Loevner et al., 1995; Van Waesberghe et al.,
1998; Miller, 2008).
The extent of lesional tissue loss is also closely linked to DTImeasures,
since expansion of extra-cellular space dramatically increases isotropic
diffusion of water molecules (Rovaris et al., 2005). Therefore, it is highly
likely that the level of RD within the lesion is affected not only by loss of
myelin sheath, but also by the level of tissue destruction. Tissue destruc-
tion may therefore ‘exaggerate’ both RD and AD (Wang et al., 2011),
masking the potential effect of remyelination on diffusivity measures.
The purpose of this study was to examine diffusivity indices in T2
and T1 lesions of MS patients. Since T1 changes, which are closely relate
to loss of tissue matrix, constitute only part of a T2 lesion, we hypothe-
sized that the T2 hyperintense lesion edge that extends beyond the T1
hypointense lesion core (whichwe called “T2-rim” area)may be less af-
fected by tissue loss, and therefore be a better target for studying the ef-
fects of de/remyelination.
The speciﬁcity of altered diffusion for pathologic changes is limited by
the wide spectrum of normal anisotropy indices in the brain (Bammer et
al., 2000). We studied lesions in the optic radiations, highly organized
ﬁbre tracts that are a frequent site of MS pathology, to facilitate accurate
measurement of relative diffusivity change along axonal bundles (Mädler
et al., 2008). In addition, internal structure of the OR does not contain a sig-
niﬁcant number of crossing ﬁbers, which can potentially (and sometimes
paradoxically) alter diffusivity (Yeatman et al., 2012; Winston, 2012). This
point is especially pertinent considering the issues that surroundmisalign-
ment between corresponding eigenvectors with the underlying tissue
structures (Wheeler-Kingshott and Cercignani, 2009).
2. Material and methods
The study was approved by University of Sydney and Macquarie
University HumanResearch Ethics Committees. All procedures followed
the tenets of the Declaration of Helsinki and written informed consent
was obtained from all participants.
2.1. Subjects
Seventy-ﬁve consecutive patients with Relapsing-Remitting MS
(RRMS) and no history of clinical optic neuritis (ON) in at least one
eye were enrolled. RRMS was deﬁned according to standard criteria
(Polman et al., 2011). A history of ONwas based on the patient's clinical
notes and the absence of previous symptoms. Patients with any other
systemic or ocular disease, in particular those that could potentially af-
fect our measurement parameters were excluded.
2.2. MRI protocol
The following sequences were acquired using a 3T GE Discovery
MR750 scanner (GE Medical Systems, Milwaukee, WI):
1. Pre- and postcontrast (gadolinium) Sagittal 3D T1: GE BRAVO se-
quence, FOV 256 mm, Slice thickness 1 mm, TE 2.7 ms, TR 7.2 ms, Flip
angle 12°, Pixel spacing 1 mm. Acquisition Matrix (Freq. × Phase) is
256 × 256, which results in 1 mm isotropic acquisition voxel size. The
reconstruction matrix is 256 × 256.2. FLAIR CUBE; GE CUBE T2 FLAIR sequence, FOV 240 mm, Slice
thickness 1.2 mm, Acquisition Matrix (Freq. × Phase) 256 × 244, TE
163 ms, TR 8000 ms, Flip angle 90°, Pixel spacing 0.47 mm. The recon-
struction matrix is 512 × 512.
3.Whole brain 64-directions diffusionweighted imagingwith 2mm
isotropic acquisition matrix (TR/TE = 8325/86 ms, b = 1000 s/mm2,
number of b0s = 2).
2.3. Reconstruction of individual optic radiations
Individual optic radiation masks was reconstructed from in-house
optic radiation template through non-linear registration as follow:
1. 3DT1 images were lesion-inpainted (FSL) using T2 lesion masks,
2. individual brain masks were derived using Brain Extraction Tool
from FSL with manual quality control,
3. deformation maps were obtained from non-linear registration be-
tween individual brain and ICBM 2009a standard brain template
(Fonov et al., 2011),
4. in-house optic radiation template was mapped into individual
patient's space through the deformation map.
2.4. Lesion identiﬁcation and analysis
Whole brain T2 lesionswere identiﬁed on the co-registered T2 FLAIR
images and segmented semi-automatically using ITK-SNAP 3 software
(http://www.itksnap.org) by a trained analyst. To minimize partial vol-
ume effect, only T2 lesions with a volume larger than 100 mm3 were
evaluated.
T1 lesions were identiﬁed on pre-contrast 3D-T1-weighted images.
They were deﬁned as regions with low signal intensity relative to the
surroundingwhitematter and correspondedwith an area of high signal
intensity on T2. The lesion (hypo-) intensity was not quantiﬁed. T2 le-
sions demonstrating Gd-enhancement were excluded from analysis.
Similar to T2 lesions, T1 lesions were segmented semi-automatically
using ITK-SNAP 3 software by a trained analyst (VF). Both T2 and T1 le-
sion segmentation was veriﬁed by two more persons, who have exten-
sive experience in lesion segmentation (AK, CW). Occasional
discrepancies were resolved by consensus.
Each T1 hypointense lesion typically occupied the central area of a
T2 lesion, leaving the peripheral part of the T2 lesion T1-isointense.
We called this part of the T2 lesion the “T2-rim” (Fig. 1). A minority of
T2 lesions did not display T1 hypointensity; these lesionswere typically
small or had a linear, elongated shape (blue arrowheads in Fig. 1), con-
tributing little to the total T2 lesion volume. Therefore, for the purpose
of analysis, T1-hypointense and T2-rim areas of T2 lesionswere evaluat-
ed separately.
Since themajority of lesions had a spherical shape, we calculated ra-
dius of T2 and T1 lesions by dividing the total lesion load by the lesion
number. In addition, the width of the T2-rim area was calculated as a
difference between the radii of T2 and T1 lesions.
Lesion masks were then intersected with the OR to identify and
measure the volume of T2, T1 and T2-rim lesions within the OR, as de-
scribed in detail elsewhere (Klistorner et al., 2015).
For single lesion analysis, only well demarcated T2 lesions with no
visible abnormality in the corresponding part of contralateral OR on
both T2 and T1 images were selected. The region of the contralateral
OR corresponding in volume and position to T2 lesionwas used as a ref-
erence representing NAWM (Fig. 2).
3. Results
Seventy-ﬁve consecutive RRMS patients (age: 41.6 ± 10.1, disease
duration: 4.9 ± 3.6 years, 25M/50F, EDSS score: 1.42 ± 1.38) were en-
rolled in the study. Patients with any other systemic or ocular diseases
were excluded. All patients were relapse-free for at least 3 months
Fig. 1. Examples of lesion segmentation. Green-T1 hypointense area, Red-“T2-rim” area. Blue arrowheads denote T2 lesions without corresponding T1 hypointensity.
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modifying therapy at the time of enrolment (7-Betaferon, 20-Copaxon,
25-Gylenia, 6-Tysabril, 8-Avonex, 2-Tecﬁdera, 2-Rebif).
A history of optic neuritis (ON) in one eye was not an exclusion
criteria, however, none of the patients had ON or visual disturbances
within 6 months of baseline assessment. All patients with history of
ON received steroid as part of ON treatment.Fig. 2. Analysis of single optic radiation lesion. a) axial view, b) coronal view, c) sagittal view. Re
122 mm2, T2-rim volume 143 mm2, contralateral ROI volume-220 mm2.There were total of 849 lesions identiﬁed on T2-FLAIR scans (Table
1). Of these, 726 lesions (86%) demonstrated (partial) hypointensity
on T1 images. The mean T1 lesion volume constituted approximately
41% of T2 lesion volume. There was highly signiﬁcant correlation be-
tween T2 andT1 lesion number, lesion volume and average single lesion
radius (r2 = 0.96, 0.92 and 0.86 respectively, p b 0.001 for all) (Fig. 3
below). However, while the volume of the T2-rim area correlatedd-T1 hypointense area, Green-“T2-rim” area, Blue-corresponding NAWM area. T1 volume
Table 1
Whole brain lesions (Mean ± SD).
Number of lesions Lesion volume mm3 Average volume of single lesion, mm3 Average radius of single lesion, mm
T2 lesions 849 5546 ± 6001 430 ± 211 4.64 ± 0.75
T1 lesions 726 2191 ± 2798 187 ± 119 3.45 ± 0.74
T2-rim area 849 3852 ± 3544 267 ± 119 1.2 ± 0.29 (width)
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was no correlation between width of T2-rim ring and T2 lesion radius
(r2=0.049, p N 0.05) indicating that thewidth of the T2-rim is indepen-
dent of the volume of T2 lesion, and remains relatively constant.
Of 75 patients, 63 (84%) demonstrated T2 lesions within the ORs.
The mean volume of OR T2, T1 and T2-rim area was 1303 ± 1269,
460 ± 558 and 836± 771 mm3 respectively. There was a highly signif-
icant correlation betweenORT2 and T1 lesion volumes (R2=0.88) (Fig.
4). OR lesion volume also correlated signiﬁcantly with whole brain le-
sion volume (r2=0.74 and r2=0.70 for T2 and T1 lesions respectively).
3.1. DTI analysis
Diffusivity coefﬁcients of entire OR and OR lesions (total T2 lesions,
T1 and T2-rim areas) are presented in Table 2.
Both RD and AD of the OR demonstrated highly positive correlations
with OR T2 lesion load (r2 = 0.69 and r2 = 0.46 respectively, p b 0.001
for both) and OR T1 lesion load (r2 = 0.59 and r2 = 0.48 respectively,
p b 0.001 for both), while OR FA was negatively correlated with volume
of OR lesions (r2=−0.53 and r2=−0.40 for T2 and T1 lesions respec-
tively, p b 0.001 for both) (Fig. 5).
Compartmentalization of T2 lesions revealed that both AD and RD
were signiﬁcantly higher in T1 areas compared to the T2-rim area, pro-
ducing a 21% rise in MD value between the two. While absolute change
in diffusivity between T2-rim and T1 areas was very similar for both RD
and AD (0.20 and 0.24), RD demonstrated slightly larger relative in-
crease compare to AD (24% vs 17% for RD and AD respectively), which
resulted in a small, but signiﬁcant drop of FA between T2-rim and T1
areas (−0.03 or 8.8%). In addition, AD and RD were highly correlated
between each other in T1 lesional areas (r2 = 0.63, p b 0.001), suggest-
ing predominantly isotropic diffusivity, while in T2-rim areas the corre-
lation was less apparent (r2 = 0.31, p b 0.01) (Fig. 6).
We have recently reported a very different pattern of diffusivity
change between OR lesional (T2) tissue and OR NAWM in a similar co-
hort of MS patients (Klistorner et al., 2015), which demonstrated more
signiﬁcant increase of RD compare to AD, resulting in substantial drop of
FA (18%) (Fig. 7). Since in the previous study the entire T2 lesional area
(including the T1 component) was analysed, it is reasonable to assume
that the difference between increase of RD andAD at theNAWM/T2-rim
border (and, as a result, the drop in FA) is even higher.
To conﬁrm thiswe performed the analysis of diffusivity in individual
OR lesions. Twenty-seven subjects had isolated T2 lesions on one side ofFig. 3. Correlation between T2 lesion radius andthe OR and normal looking white matter in the corresponding part of
the contralateral OR (which was used as a reference area analogous to
NAWM). Diffusivity of T1 and T2-rim areas of the lesions were mea-
sured separately.
The result of this single lesion analysis (Table 3) demonstrated that
RD continued to increase from NAWM to T2-rim area and then to T1
area with equal increments (0.20 and 0.20) The gradient of AD rise,
however, increased from 0.10 at the border between NAWM and T2-
rim area to 0.20 at the border between T2-rim and T1 areas. This was
reﬂected in a more substantial drop of FA at NAWM/T2-rim border
(−0.12) compared to T2-rim/T1 border (−0.05).
In addition, a signiﬁcant positive correlation was found between the
level of diffusivity in T2 lesions and the proportion of the lesion occu-
pied by T1 hypointensity (Fig. 8). Linear Regression analysis indicated
that not only N65% of AD variability, but also more than half of RD var-
iability in T2 lesions can be explained by the relative size of T1
hypointensity and, therefore, is related to the extent (and probably se-
verity) of axonal loss.4. Discussion
In the current studywe examined the directional diffusivity inOR le-
sions of RRMS patients. Application of novel compartmentalized ap-
proach suggested new way of assessing lesional diffusivity which may
facilitate the measurement of demyelination/remyelination in deep
brain lesions and potentially serve as an outcomemeasure in therapeu-
tic trials of emerging pro-reparative treatment.
We demonstrated a high correlation of both T2 and T1 OR lesion vol-
ume with whole brain lesional load, supporting the use of the OR as a
model of pathological activity in MS. We also conﬁrmed our previous
observation that the major part of OR DTI variability is associated with
lesional damage (Klistorner et al., 2014). However, while RD ismore de-
pendent on lesion volume, the variation of AD is probably impacted by
other factors, including severity of the structural damage within the le-
sions and Wallerian degeneration (Klistorner et al., 2015).
Various patterns of abnormal diffusivity in T2 vs T1 lesions have
been previously described in MS. In chronic lesions the most common
ﬁnding was increased water diffusion (ADC or MD) and reduced FA in
lesional tissue compared to NAWM; and more marked diffusion alter-
ations were present in T1 hypointense lesions compared to T1
isointense lesions (Filippi et al., 2001; Droogan et al., 1999; Bammer et: a) T1 lesion radius, b) T2-rim area width.
Fig. 4. Correlation between OR T2 and T1 lesion volume.
Fig. 5. Correlation between OR T2 lesion volume and OR diffusivity coefﬁcients including
AD, RD and FA.
223A. Klistorner et al. / NeuroImage: Clinical 12 (2016) 219–226al., 2000; Scanderbeg et al., 2000; Werring et al., 1999; or see Sbardella
et al., (2013) for review).
Since primary identiﬁcation of the lesions was always based on T2-
weighted (and proton density) images, in earlier studies the term “T1
isointense lesion” simply meant “pure” (i.e. not detectable on T1 im-
ages) T2 lesions, while the term “T1 hypointense lesion” was used to
mark those T2 lesions which contained areas of low signal intensity on
T1 non-contrast images. The relative number of reported hypointense
T1 lesions varied between studies from as low 10% to as high as 70% of
total lesion number (Filippi et al., 2001; Werring et al., 1999; Bammer
et al., 2000; Nusbaum et al., 2000). This disagreement can potentially
be related to the different deﬁnitions of T1 hypointensity. Thus, in
some studies the intensity of the lesions on T1 images was compared
to the surrounding NAWM (Filippi et al., 2001; Scanderbeg et al.,
2000; Werring et al., 1999), while in others-to the grey matter
(Nusbaum et al., 2000), while in others several levels of hypointensity
were used(Loevner et al., 1995).
Here we used the most frequently reported deﬁnition of T1
hypointensity: an area of low T1 signal intensity in comparison to the
surrounding NAWM. We demonstrated that the vast majority (86%) of
T2 lesions correspond with areas of T1 hypointensity. The high rate of
detection of the T1 hypointensity found in our study may partially be
explained by the better resolution of our imaging technique, which
employed 1mmslices, compared to 5mmslice thickness used in earlier
studies and use of 3D T1 sequence. In addition, inclusion of slightly
hypointense lesions may also increase the rate of T1 lesions reported
here.
Segmentation of the T2 lesions was also performed differently from
some of the earlier studies. Previously the entire area of T2 lesions
displaying abnormal T1 signal was marked and analysed as “T1
hypointense lesion”, even if it was only partially occupied by T1
hypointensity (as was frequently the case) (Loevner et al., 1995;
Filippi et al., 2001; Bammer et al., 2000;Werring et al., 1999). In the cur-
rent study, however, every lesion displaying T1 signal abnormality was
segmented (compartmentalized) into two areas: genuine T1 area
(which represented a part of T2 lesion seen as hypointense area on
T1-weighted images) and “T2-rim” area, which corresponded with theTable 2
Diffusivity coefﬁcients of OR and OR lesions (Mean (SD)).
AD RD FA MD
Entire OR 1.17 (0.04) 0.68 (0.05) 0.35 (0.03) 0.85 (0.05)
T2 lesions 1.47 (0.15) 0.87 (0.10) 0.33 (0.04) 1.07 (0.11)
T1 area 1.62 (0.22) 1.00 (0.14) 0.31 (0.05) 1.22 (0.14)
T2-rim area 1.39 (0.17) 0.81 (0.08) 0.34 (0.05) 1.01 (0.08)component of the T2 lesion not visible (i.e. isointense) on T1-weighted
images. Diffusivity of both areas was analysed separately, an approach
that we hypothesized would provide better insight into the nature of
diffusivity and its relationshipwith demyelinating and destructive com-
ponents of lesional pathology.
In addition, the use of primary eigenvalues (AD and RD) rather than
composite indices (ADC, MD or FA) employed in earlier studies, may
also be beneﬁcial in understanding mechanisms of diffusivity
change(Aung et al., 2014; Klistorner et al., 2015; Schmierer et al., 2007).
Segmentation of T2 lesions demonstrated that the area of T1
hypointensity typically occupies the central area of the lesion, leaving
Fig. 6. Correlation between AD and RD in: a) T1 area, b) “T2-rim” area.
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pathological changes occurring within the lesion. T2-hyperintensity,
while pathologically non-speciﬁc, marks the external border of the en-
tire chronically demyelinated area (Schmierer et al., 2009). Conversely,
T1 hypointensity is linked tomore severe tissue damage caused by axo-
nal loss and resultingwidening of the extracellular space (Loevner et al.,
1995; VanWaesberghe et al., 1998; vanWalderveen et al., 1998; Brex et
al., 2000). Therefore, destructive changes are likely to primarily impact
MRI appearance and diffusion metrics in the central part of the lesion,
masking to a large degree any effect of demyelination. In contrast, rela-
tive preservation of axons in the peripheral part of the lesionwould ren-
der demyelination the key pathological feature. As a consequence, the
rim of the lesion, while isointense on T1, remains visible on T2-weight-
ed images.
This hypothesis is supported by OR diffusivity data. While the cur-
rent study revealed a signiﬁcant increase of diffusivity (both RD and
AD) toward the center of the lesion, RD demonstrated a
disproportionally high (in relation to AD) increase between NAWM
and T2-rim areas in comparison with the changes observed between
T2-rim and T1 areas. This resulted in a reduced rate of FA decline,
which changed from 0.12 at the NAWM/T2-rim border to only 0.05 at
T2-rim/T1 border.
Since an increase of RD (but not AD) is believed to be related to the
degree of demyelination (Schmierer et al., 2007; Klawiter et al., 2011;
Song et al., 2005), our results, which show a much larger change of RD
compared to AD at the NAWM/T2-rim border, suggest signiﬁcant lossFig. 7. Change of diffusivity coefﬁcients at the borders of NAWM-“T2-rim” area and “T2-
rim”-T1 area. While RD increases to exactly the same amount between NAWM and “T2-
rim” area and between “T2-rim” area and T1 area, increase of AD is much more
pronounced between “T2-rim” area and T1 area compare to border between NAWM
and “T2-rim” area. This results in signiﬁcantly larger drop of FA between NAWM and
“T2-rim” area compare to border between “T2-rim” area and T1 area. Vertical axis
represents change in diffusivity for RD, AD (μm2/ms for both) and FA (arbitrary units).of myelin in T2-rim area. In contrast, similar changes of RD and AD at
T2-rim/T1 border imply more isotropic diffusion in the central (T1)
part of the lesion, which is indicative of severe tissue destruction and
widening of the extracellular space, in agreement with the previously
reported association between lesion T1 hypointensity and the degree
of diffusion (Scanderbeg et al., 2000; Werring et al., 1999; Filippi et al.,
2000; Rovaris et al., 2005). Differences in directional diffusivity between
T2-rim and T1 areas are also reﬂected in a larger reduction of FA at
NAWM/T2-rim compare to T2-rim/T1 borders.
The mostly isotropic diffusion in T1 lesions also reﬂects a very high
correlation between AD and RD within this area, while in T2-rim areas
the correlation was less apparent (r2 = 0.63 vs 0.31). This also supports
the assumption that a mechanism responsible for the comparable in-
crease of both RD and AD (such as enlargement of an extra-cellular
space due to axonal loss) dominates the changes in diffusivity in the
T1 area.
Compared to T1 lesions the standard deviation of RD in T2-rim areas
was notably smaller, possibly reﬂecting similar degree of demyelin-
ation, whereas the severity of tissue destruction and axonal loss,
which is an additional factor contributing to themagnitude of diffusivity
in the T1 area, may vary considerably (Kolasinski et al., 2012; van
Walderveen et al., 1998; Lassmann et al., 1994).
An alternative explanation for the different patterns of diffusivity in
the peripheral vs central part of the lesion could be partial
remyelination, which is typically observed at the border of the chronic
MS lesion and is likely to be visible on T2-weighted images as a mildly
hyperintense area (Nijeholt et al., 2001)(van Walderveen et al., 1998).
It is conceivable that more severe loss of myelin in the central area of
the lesion contributes towidening of the extracellular space (particular-
ly considering the large relative volume of myelin sheath compare to
axonal volume (Mohammadi et al., 2015)). However, based on the no-
tion that an increase in RD is linked to loss of myelin, while change of
AD is largely associated with axonal degeneration, severe demyelin-
ation alone could not explain the mostly isotropic nature of diffusivity
increase toward the center of the lesion.
Regardless of the origin of the expanded extra-cellular space (which
may be a combined effect of axonal loss, severe demyelination and post-
inﬂammatory cavitation), increased tissue water content alone will re-
sult in an isotropic rise in diffusivity, reducing the potential sensitivity
of RD to de/remyelination (Klawiter et al., 2011; Wang et al., 2015;
Wang et al., 2011). This is consistent with our ﬁnding that isotropicTable 3
Diffusivity coefﬁcients of OR single lesions (Mean (SD)).
AD RD FA MD
NAWM 1.39 (0.11) 0.61 (0.07) 0.49 (0.05) 0.87 (0.06)
T2-rim area 1.49 (0.12) 0.82 (0.08) 0.37 (0.05) 1.04 (0.07)
T1 area 1.69 (0.15) 1.02 (0.17) 0.32(0.07) 1.25 (0.15)
Fig. 8. Correlation between lesional diffusivity and proportional size of the T1 hipointense area within T2 lesion: a) RD, b) AD.
225A. Klistorner et al. / NeuroImage: Clinical 12 (2016) 219–226increase of diffusivity in the T1 lesion area signiﬁcantly contributes to
RD of the T2 lesion area.
Another important observation in the current study relates to the
width of T2-rim area, which remained constant regardless of the lesion
volume. While the signiﬁcance of this fact remains obscure, it may re-
ﬂect relative preservation of axons at the lesion edge. Conversely, it
may be related to the partial remyelination, which is often limited to
the lesion border. We previously demonstrated that the degree of
remyelination following optic neuritis, is relatively constant and does
not correlate with lesion size (Klistorner et al., 2010). However, since
axonal survival and remyelination are intimately linked (preserved
axons are needed to initiate remyelination, while remyelinated ﬁbers
are better preserved), a combination of both factors may be responsible
for the phenomenon observed in this study. The constant T2-rim width
may also explainwhy small T2 lesionswith a linear, elongated shape do
not always display associated T1 hypointensity; T2-rim areas from op-
posite sides of the lesion may simply ﬁll its entire cross-section. This is
supported by the observation that conversion of T1 acute lesions to
chronic black holes is size-dependent (Van Waesberghe et al., 1998).
In conclusion, our results demonstrate different patterns of diffusiv-
ity between central and peripheral parts of the MS lesions, and we pro-
pose that axonal loss dominates the former, while the effect of de/
remyelination may potentially be better detected in the latter. Identify-
ing and separating those patterns has important implications for clinical
trials of both neuroprotective and, in particular, remyelinating agents.
Disentangling the effects of multiple mechanisms may considerably in-
crease the sensitivity ofMRI techniques tomonitor subtle changes of ax-
onal loss and myelination.References
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